JP2021070685A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021070685A5 JP2021070685A5 JP2020172258A JP2020172258A JP2021070685A5 JP 2021070685 A5 JP2021070685 A5 JP 2021070685A5 JP 2020172258 A JP2020172258 A JP 2020172258A JP 2020172258 A JP2020172258 A JP 2020172258A JP 2021070685 A5 JP2021070685 A5 JP 2021070685A5
- Authority
- JP
- Japan
- Prior art keywords
- magnesium
- component
- mass
- solid preparation
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007787 solid Substances 0.000 claims 14
- 238000002360 preparation method Methods 0.000 claims 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 10
- 244000134552 Plantago ovata Species 0.000 claims 7
- 235000003421 Plantago ovata Nutrition 0.000 claims 7
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims 6
- 239000000347 magnesium hydroxide Substances 0.000 claims 6
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims 6
- 239000000395 magnesium oxide Substances 0.000 claims 6
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims 6
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 5
- 235000019341 magnesium sulphate Nutrition 0.000 claims 5
- 239000008141 laxative Substances 0.000 claims 4
- 159000000003 magnesium salts Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 claims 3
- 229960000503 bisacodyl Drugs 0.000 claims 3
- 229940125722 laxative agent Drugs 0.000 claims 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims 3
- 239000001095 magnesium carbonate Substances 0.000 claims 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000007910 chewable tablet Substances 0.000 claims 1
- 229940068682 chewable tablet Drugs 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 230000002475 laxative effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000006191 orally-disintegrating tablet Substances 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024213029A JP7862785B2 (ja) | 2019-10-28 | 2024-12-06 | 固形製剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019195376 | 2019-10-28 | ||
| JP2019195376 | 2019-10-28 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213029A Division JP7862785B2 (ja) | 2019-10-28 | 2024-12-06 | 固形製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021070685A JP2021070685A (ja) | 2021-05-06 |
| JP2021070685A5 true JP2021070685A5 (cg-RX-API-DMAC7.html) | 2023-10-13 |
| JP7634160B2 JP7634160B2 (ja) | 2025-02-21 |
Family
ID=75714017
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020172258A Active JP7634160B2 (ja) | 2019-10-28 | 2020-10-13 | 固形製剤 |
| JP2024213029A Active JP7862785B2 (ja) | 2019-10-28 | 2024-12-06 | 固形製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213029A Active JP7862785B2 (ja) | 2019-10-28 | 2024-12-06 | 固形製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP7634160B2 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232698A (en) * | 1992-06-12 | 1993-08-03 | The Proctor & Gamble Company | Psyllium drink mix compositions |
| US5356618A (en) * | 1993-05-14 | 1994-10-18 | The Procter & Gamble Company | Psyllium drink mix compositions |
| JP2001199894A (ja) | 2000-01-19 | 2001-07-24 | Taisho Pharmaceut Co Ltd | 緩下剤 |
| JP2001220352A (ja) | 2000-02-08 | 2001-08-14 | Taisho Pharmaceut Co Ltd | 瀉下薬 |
| WO2008141368A1 (en) | 2007-05-17 | 2008-11-27 | David Lubowski | Combination laxative compositions comprising a colonic stimulant and a bulking laxative |
-
2020
- 2020-10-13 JP JP2020172258A patent/JP7634160B2/ja active Active
-
2024
- 2024-12-06 JP JP2024213029A patent/JP7862785B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023165999A5 (cg-RX-API-DMAC7.html) | ||
| CN104288112A (zh) | 一种盐酸左氧氟沙星片剂 | |
| JP2022105649A5 (cg-RX-API-DMAC7.html) | ||
| JP2008516004A5 (cg-RX-API-DMAC7.html) | ||
| US4198435A (en) | Pharmaceutical compositions | |
| JP2024501839A5 (cg-RX-API-DMAC7.html) | ||
| FI3993777T3 (fi) | Kompressoidut masitentaanikoostumukset, menetelmät ja niiden käytöt | |
| CA2461576A1 (en) | Process for the preparation of tablets comprising s-adenosylmethionine | |
| JP2009514786A5 (cg-RX-API-DMAC7.html) | ||
| RU2016129069A (ru) | Композиции и способы ингибирования воспаления и заболеваний с применением антимикробного соединения на основе альгиновой кислоты | |
| CN101804030A (zh) | 一种双氯芬酸钠微丸制剂及其制备方法 | |
| US4000254A (en) | Fungimycin compositions | |
| RU2010153977A (ru) | Композиции, содержащие euphorbia prostrata, и способ их получения | |
| WO2010080977A2 (en) | Oral sustained release antidepressant formulation | |
| JPWO2024111636A5 (cg-RX-API-DMAC7.html) | ||
| US4064230A (en) | Polyenic macrolide compositions | |
| WO1999062559A1 (en) | Pharmaceutical tablets comprising cefuroxime axetil | |
| CN101269055A (zh) | 盐酸氨溴索口腔崩解片及其制备方法 | |
| CN101849939A (zh) | 一种以异丙托溴铵与沙丁胺醇为主要活性成分的药物组合物 | |
| CN101756924A (zh) | 法罗培南钠的缓释片 | |
| RU2147878C1 (ru) | Фармацевтическая композиция, обладающая энтеральным действием | |
| CN100584339C (zh) | 无机碳酸盐的用途 | |
| JPS5938206B2 (ja) | 補酵素ｑを主成分とする気管支喘息治療剤 | |
| CN102309468A (zh) | 一种盐酸左旋沙丁胺醇口服控释片剂胶囊及其制备方法 | |
| US1976668A (en) | Pharmaceutical preparation |